tm logo
VYSINARA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 25 Nov 2019

Last Applicant/ Owned by

One Johnson & Johnson Plaza

New Brunswick

NJ

08933

Serial Number

87004365 filed on 18th Apr 2016

Registration Number

N/A

Correspondent Address

CHERYL L. FOYTLIN

JOHNSON & JOHNSON

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK, NJ 08933

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VYSINARA

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; contraceptive preparations; vaccines

Classification Information


Class [005]
Pharmaceutical Products


Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; contraceptive preparations; vaccines

Mark Details


Serial Number

No 87004365

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T32153US3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Nov 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
25th Nov 2019ABANDONMENT - NO USE STATEMENT FILED
26th Mar 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25th Mar 2019EXTENSION 5 GRANTED
25th Mar 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
19th Mar 2019EXTENSION 5 FILED
19th Mar 2019TEAS EXTENSION RECEIVED
03rd Oct 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01st Oct 2018EXTENSION 4 FILED
01st Oct 2018EXTENSION 4 GRANTED